ClinicalTrials.gg

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Program

V118C

A development code. Also written as “V118C (Stage 1)” and “V118C (Stage 2)”.

Its studies are mostly in Pneumococcal Infections, led by Merck.

Furthest: phase 1, since Sep 20, 20242 company-led studies, 1 open or runningNext primary completion: Oct 24, 2028 (phase 1)

Who develops it

Each company that leads studies of it, as its sponsor page counts them.

CompanyStudies it leadsFurthest phaseFirst studyNext primary completion
Merck21 open or runningphase 1since Sep 20, 2024Sep 20, 2024Oct 24, 2028phase 1 · NCT07300267

History and what’s ahead

From the studies’ own records, by the day each was first submitted. Purple marks an event: a company’s first study, a phase reached, a study stopped, a primary completion moved later (stops and moved dates are recorded from Sep 25, 2026). Dates ahead are the sponsors’ estimates.

  1. Sep 20, 2024First study: phase 1 study in HealthyFirst studyNCT06611033 · 65 enrolled · United States
  2. Dec 10, 2025Phase 1 study in Pneumococcal InfectionsNCT07300267 · 210 planned · United States

Ahead

  1. Oct 24, 2028Primary completion: phase 1 study in Pneumococcal InfectionsNCT07300267

TargetBeta

Not stated by its company or a source we have read. Most early programs say nothing of it.

Studies

All 2 led by companies developing it, newest first. Each opens its study page.

StudyPhaseStatusPrimary completionSize
NCT07300267Pneumococcal Infections · United States1RecruitingOct 24, 2028210
NCT06611033Healthy · United States1CompletedJan 9, 202665

How it is read

Names in the registry

  • “V118C (Stage 1)”, 1 entry
  • “V118C (Stage 2)”, 1 entry
  • “V118C”, 1 entry

Codes read as this program: V118C.

Conditions, from the studies’ own filings

First seen by our ledger Nov 13, 2026.

What this can’t show

  • Only studies on ClinicalTrials.gov. Studies only in China’s, Europe’s or other registries are missing here.
  • Deals, prices and results are not in the registry. A licence or acquisition shows only with a dated source.
  • Primary completion dates are the sponsors’ estimates and often move.
  • A study counts here when it names this program among the drugs it tests; one that writes it only beside a placebo may be missed.